Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study to Evaluate the Use of Thrombopoietin Receptor Agonists (TPO-ra) in Adults With Primary Immune Thrombocytopenia (ITP) in Europe

NCT06408324 is registered in ClinicalTrials.gov with European Research Consortium on ITP as lead sponsor.

NCT NCT06408324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06408324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study to Evaluate the Use of Thrombopoietin Receptor Agonists (TPO-ra) in Adults With Primary Immune Thrombocytopenia (ITP) in Europe
Lead sponsor
European Research Consortium on ITP
Phase
Observational
Overall status
Completed
Start date
November 24, 2022
Completion date
April 5, 2024
Enrollment
275 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

primary immune thrombocytopenia (itp)